Halal Pharmaceuticals - Regulatory Perspectives
of 28
Transcript of Halal Pharmaceuticals - Regulatory Perspectives
-
7/23/2019 Halal Pharmaceuticals - Regulatory Perspectives
1/28
J\DO
-
7/23/2019 Halal Pharmaceuticals - Regulatory Perspectives
2/28
J\DO
\rkskjtbtfij Iutafjk
Fjtrinudtfij
Gbabysfbj Jbtfijba Gknfdfjks \iafdy (GJG\)
Nru` Dijtria Buthirfty- NDB \iafdy ij HBABA
@kjkrba @ufnkafjks GT?>?>=?
-
7/23/2019 Halal Pharmaceuticals - Regulatory Perspectives
3/28
J\DO
Fjtrinudtfij ti GJG\
4
B dakbr bjn iccfdfba `ivkrjgkjt stbtkgkjt thbt nkcfjks bjn prfirftfzksthk gknfug-ti aij` tkrg-`ibas skt oy thk `ivkrjgkjt cir thk
phbrgbdkutfdba skdtir
B cirgba rkdirn ic bspfrbtfijs, bfgs, nkdfsfijs bjn diggftgkjts ic thk
`ivkrjgkjt bjn baa stbekhiankrs fj oith puoafd bjn prfvbtk skdtirs ti b
diggij `iba cir thk phbrgbdkutfdba skdtir
Fnkjtfcfks strbtk`fks bjn privfnks b trbjspbrkjt crbgkwire cir thk
diirnfjbtkn fgpakgkjtbtfij ic thksk strbtk`fks oy stbekhiankrs fj thk
puoafd bjn prfvbtk skdtirs
Kxfstfj` ak`fsabtfij dbj privfnk thk kxkdutfvk piwkr bjn ak`ba crbgkwire
ti fgpakgkjt thk JG\
\rkskjdk ic ir`bjfzbtfijs fj GIH ti ivkrskk, gijftir bjn bngfjfstkr
thk ak`fsabtfij
>
-
7/23/2019 Halal Pharmaceuticals - Regulatory Perspectives
4/28
J\DO
>
^i fgprivk hkbath iutdigks ic Gbabysfbjs thriu`h=
\rigitfj` kquftboak bddkss ti ksskjtfba
gknfdfjks
Kjsurfj` bvbfabofafty ic sbck, kcckdtfvk bjnbccirnboak gknfdfjks ic `iin qubafty
\rigitfj` qubafty usk ic gknfdfjks oyhkbathdbrk privfnkrs bjn dijsugkrs
Iomkdtfvks ic GJG\/N[Jbs
-
7/23/2019 Halal Pharmaceuticals - Regulatory Perspectives
5/28
J\DO
;
Ttrbtk`fd pbrtjkrshfps wfththk rkakvbjt buthirftfks tigbek dkrtfcfkn hbabagknfdfjks bvbfaboak fjGbabysfb.
Hbaba
Gknfdfjks
Bvbfabofafty ic Gknfdfjks Tkakdtfij ic Gknfdfjks
-
7/23/2019 Halal Pharmaceuticals - Regulatory Perspectives
6/28
J\DO
GBABVTFB= Cfrst
Gbabysfbj Hbaba
\hbrgbdkutfdba
Ttbjnbrn cirOkttkr Hkbathdbrk
- B Cfrst cir thk
Piran
Orkbefj` Jkws
3
-
7/23/2019 Halal Pharmaceuticals - Regulatory Perspectives
7/28
J\DO
0
^iyyfobj (NDB)
Rubafty, Tbckty & Kccfdbdy
@G\, \rk & \ist _k`fstrbtfijrkqufrkgkjts, @N\
\iafdfks ktd
Hbababj UbaaiwboakW
& iyyfobj UsbckW
Hbababj (MBEFG)
-
7/23/2019 Halal Pharmaceuticals - Regulatory Perspectives
8/28
J\DO
8
N_[@ DIJ^_IAB[^HI_F^V NDB
\FHBE OK_E[BTBEBPBABJ NBNBH- \OEN
-
7/23/2019 Halal Pharmaceuticals - Regulatory Perspectives
9/28
J\DO
6 6
_k`uabtirs dijdkrj
.\hbrgbdkutfdbas
Rubafty, Tbckty bjn KccfdbdyUEubaftf, Ekskabgbtbj nbj EkokreksbjbjW
-
7/23/2019 Halal Pharmaceuticals - Regulatory Perspectives
10/28
J\DO
2< 2
Durrkjt NDBs \iafdy ij HBABA
Baaiws HBABAabokas ij=
Disgktfds, ^rbnftfijba Gkn
Hkbath Tuppakgkjts
I^D U?
-
7/23/2019 Halal Pharmaceuticals - Regulatory Perspectives
15/28
J\DO
Ckqbh \rfjdfpaks
^i pritkdt afck fs tip prfirfty
Phkj fj nbrurbtUkgkr`kjdy ir whkj
thkrk fs ji dhifdkW usfj` ic jij-hbaba fshbrus
Dijtfjuius qukst fj skbrdh ic hbaba
2;
-
7/23/2019 Halal Pharmaceuticals - Regulatory Perspectives
16/28
J\DO
HBABA \hbrgbdkutfdbas=
@kjkrba @ufnkafjks GT ?>?> ?
-
7/23/2019 Halal Pharmaceuticals - Regulatory Perspectives
17/28
J\DO
GT ?>?>=?
-
7/23/2019 Halal Pharmaceuticals - Regulatory Perspectives
18/28
J\DO
Phbt fs Hbaba \hbrgbdkutfdbas9
\hbrgbdkutfdba prinudts thbt dijtbfj
fj`rknfkjts pkrgfttkn ujnkr thk Thbrfbh abw
& cuacfaa thk ciaaiwfj` dijnftfijs=
b) ni jit dijtbfj bjy pbrts ir prinudts icbjfgbas thbt brk jij-hbabair bjy pbrts ir
prinudts ic bjfgbas whfdh brk jitsabu`htkrkn bddirnfj` ti Thbrfbh abw5
o) ni jit dijtbfj jbms
28
-
7/23/2019 Halal Pharmaceuticals - Regulatory Perspectives
19/28
J\DO
Phbt fs Hbaba \hbrgbdkutfdbas9
d) sbckcir dijsugptfij, jij-pifsijius, jij-fjtixfdbtfj` ir jij-hbzbrnius ti hkbathbddirnfj` ti prksdrfokn nisb`k5
n) jit prkpbrkn, pridksskn ir gbjucbdturknusfj` kqufpgkjt dijtbgfjbtkn wfth jbms5
k) ni jit dijtbfj bjy hugbj pbrts ir ftsnkrfvbtfvksthbt brk jit pkrgfttkn oyThbrfbh abw5 bjn
26
-
7/23/2019 Halal Pharmaceuticals - Regulatory Perspectives
20/28
J\DO
Phbt fs Hbaba \hbrgbdkutfdbas9
c) nurfj` fts prkpbrbtfij, pridkssfj`,
hbjnafj`, pbdeb`fj`, stirb`k bjn
nfstrfoutfij, thk hbabaphbrgbdkutfdba
prinudts brk physfdbaay skpbrbtkncrigbjy ithkr phbrgbdkutfdba prinudts thbt
ni jit gkkt thk rkqufrkgkjts stbtkn fj
ftkgs b), o), d), n) ir k) ir bjy ithkrftkgs thbt hbvk okkj nkdrkkn bs jij-
hbababjn jbms oy Thbrfbh abw.
?. Nidugkjtbtfij
Dh. ;. \rinudtfijDh. 3. Rubafty Dijtria
Dh. 0. Dijtrbdt Gbjucbdturk bjn Bjbaysfs
Dh. 8. Digpabfjt bjn \rinudt _kdbaa
Dh. 6. Tkac Fjspkdtfij
Bjjkxks 2-?< (spkdfcfd)
KAKGKJ^T IC \FD/T@G\
-
7/23/2019 Halal Pharmaceuticals - Regulatory Perspectives
23/28
J\DO
Hbaba dkrtfcfdbtks
^hk hbaba dkrtfcfdbtks shbaa ok fssukn oy
thk digpktkjt buthirfty UMBEFGW fj
Gbabysfb MBEFG Nkpt ic Fsabgfd Nkvkaipgkjt ic
Gbabysfb
02 rkdi`jfskn oinfks fj ?6 diujtrfks
?4
-
7/23/2019 Halal Pharmaceuticals - Regulatory Perspectives
24/28
J\DO
HBABA O[FA^-FJJit tkstkn cir
?>
-
7/23/2019 Halal Pharmaceuticals - Regulatory Perspectives
25/28
J\DO
Digpafbjdk ti\FD/T
@ufnk ti @iin
Gbjucbdturfj`
\rbdtfdk
Cir gknfdfjba\rinudts
&
Bjjkxks
HbabaBssurbjdk
Tystkg
Hbaba
Diggfttkk
HbabaCbdfafty
ktd
Tiurdk
ic
gbtkrfbas
^hfj`s
thbt
digk fjDijtbdt
wfth
Hbaba
oufat-fj
_kdi`.
oiny
?;
-
7/23/2019 Halal Pharmaceuticals - Regulatory Perspectives
26/28
J\DO
Pk digpafgkjts kbdh ithkr!
?3
-
7/23/2019 Halal Pharmaceuticals - Regulatory Perspectives
27/28
J\DO
?0?0
^i _kvfkw thk Nru` _k`fstrbtfij @ufnbjdk Nidugkjt
([sk ic Hbaba Ai`i)
Bwbrkjkss ij GT?>?>=?
-
7/23/2019 Halal Pharmaceuticals - Regulatory Perspectives
28/28
J\DO
www.opce.`iv.gy
?8
